• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

S100A11 分泌蛋白与外泌体 miR-487a-5p 协同抑制 NUDT21 促进黑素瘤寡转移至多转移进展。

Synergistic inhibition of NUDT21 by secretory S100A11 and exosomal miR-487a-5p promotes melanoma oligo- to poly-metastatic progression.

机构信息

Institute of Life Sciences, Chongqing Medical University, China.

State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, China.

出版信息

Mol Oncol. 2023 Dec;17(12):2743-2766. doi: 10.1002/1878-0261.13480. Epub 2023 Jul 1.

DOI:10.1002/1878-0261.13480
Abstract

Although early diagnosis and therapeutic advances have transformed the living quality and outcome of cancer patients, the poor prognosis for metastatic patients has not been significantly improved. Mechanisms underlying the complexity of metastasis cannot be simply determined by the straightforward 'cause-and-effect relationships'. We have developed a 'dry-lab-driven knowledge discovery and wet-lab validation' approach to embrace the complexity of cancer and metastasis. We have revealed for the first time that polymetastatic (POL) melanoma cells can utilize both the secretory protein pathway (S100A11-Sec23a) and the exosomal crosstalk (miR-487a-5p) to transfer their 'polymetastatic competency' to the oligometastatic (OL) melanoma cells, via synergistic co-targeting of the tumor-suppressor Nudt21. The downstream deregulated glycolysis was verified to regulate metastatic colonization efficiency. Further, two gene sets conferring independent prognosis in melanoma were identified, which have the potential for clinical translation and merit future clinical validation.

摘要

尽管早期诊断和治疗进展已经改变了癌症患者的生活质量和预后,但转移性患者的预后仍未得到显著改善。转移的复杂性机制不能简单地通过直接的“因果关系”来确定。我们开发了一种“干实验驱动的知识发现和湿实验验证”方法来应对癌症和转移的复杂性。我们首次揭示了多转移(POL)黑色素瘤细胞可以利用分泌蛋白途径(S100A11-Sec23a)和外泌体串扰(miR-487a-5p),通过协同靶向肿瘤抑制因子 Nudt21,将其“多转移能力”转移到寡转移(OL)黑色素瘤细胞中。下游失调的糖酵解被证实可调节转移定植效率。此外,还鉴定了两个在黑色素瘤中具有独立预后作用的基因集,它们具有临床转化的潜力,值得未来的临床验证。

相似文献

1
Synergistic inhibition of NUDT21 by secretory S100A11 and exosomal miR-487a-5p promotes melanoma oligo- to poly-metastatic progression.S100A11 分泌蛋白与外泌体 miR-487a-5p 协同抑制 NUDT21 促进黑素瘤寡转移至多转移进展。
Mol Oncol. 2023 Dec;17(12):2743-2766. doi: 10.1002/1878-0261.13480. Epub 2023 Jul 1.
2
Exosomal miR-211-5p regulates glucose metabolism, pyroptosis, and immune microenvironment of melanoma through GNA15.外泌体 miR-211-5p 通过 GNA15 调节黑色素瘤的糖代谢、焦亡和免疫微环境。
Pharmacol Res. 2023 Feb;188:106660. doi: 10.1016/j.phrs.2023.106660. Epub 2023 Jan 13.
3
Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression.Sec23a 介导 miR-200c 增强的寡转移向多转移进展。
EBioMedicine. 2018 Nov;37:47-55. doi: 10.1016/j.ebiom.2018.10.002. Epub 2018 Oct 6.
4
Exosomal long noncoding RNA MLETA1 promotes tumor progression and metastasis by regulating the miR-186-5p/EGFR and miR-497-5p/IGF1R axes in non-small cell lung cancer.外泌体长链非编码 RNA MLETA1 通过调控非小细胞肺癌中 miR-186-5p/EGFR 和 miR-497-5p/IGF1R 轴促进肿瘤进展和转移。
J Exp Clin Cancer Res. 2023 Oct 26;42(1):283. doi: 10.1186/s13046-023-02859-y.
5
High-Metastatic Melanoma Cells Promote the Metastatic Capability of Low-Metastatic Melanoma Cells Exosomal Transfer of miR-411-5p.高转移性黑色素瘤细胞通过外泌体转移miR-411-5p促进低转移性黑色素瘤细胞的转移能力
Front Oncol. 2022 May 20;12:895164. doi: 10.3389/fonc.2022.895164. eCollection 2022.
6
Exosomal miR-106b-5p derived from melanoma cell promotes primary melanocytes epithelial-mesenchymal transition through targeting EphA4.外泌体 miR-106b-5p 来源于黑素瘤细胞,通过靶向 EphA4 促进原代黑素细胞上皮-间充质转化。
J Exp Clin Cancer Res. 2021 Mar 19;40(1):107. doi: 10.1186/s13046-021-01906-w.
7
Nudt21 regulates the alternative polyadenylation of Pak1 and is predictive in the prognosis of glioblastoma patients.Nudt21 调控 Pak1 的可变多聚腺苷酸化,并且可预测胶质母细胞瘤患者的预后。
Oncogene. 2019 May;38(21):4154-4168. doi: 10.1038/s41388-019-0714-9. Epub 2019 Jan 31.
8
miR-4454 up-regulated by HPV16 E6/E7 promotes invasion and migration by targeting ABHD2/NUDT21 in cervical cancer.HPV16 E6/E7 上调的 miR-4454 通过靶向 ABHD2/NUDT21 促进宫颈癌的侵袭和迁移。
Biosci Rep. 2020 Sep 30;40(9). doi: 10.1042/BSR20200796.
9
Melanoma stem cells promote metastasis via exosomal miR-1268a inactivation of autophagy.黑色素瘤干细胞通过外泌体 miR-1268a 抑制自噬促进转移。
Biol Res. 2022 Oct 1;55(1):29. doi: 10.1186/s40659-022-00397-z.
10
miRNA-487a Promotes Proliferation and Metastasis in Hepatocellular Carcinoma.miRNA-487a 促进肝癌的增殖和转移。
Clin Cancer Res. 2017 May 15;23(10):2593-2604. doi: 10.1158/1078-0432.CCR-16-0851. Epub 2016 Nov 8.

引用本文的文献

1
S100A11 as an immune-related exosomal driver of colorectal cancer progression: a novel diagnostic biomarker.S100A11作为结直肠癌进展的免疫相关外泌体驱动因子:一种新型诊断生物标志物
Front Oncol. 2025 Jun 11;15:1590128. doi: 10.3389/fonc.2025.1590128. eCollection 2025.
2
Multi-stage mechanisms of tumor metastasis and therapeutic strategies.肿瘤转移的多阶段机制与治疗策略。
Signal Transduct Target Ther. 2024 Oct 11;9(1):270. doi: 10.1038/s41392-024-01955-5.
3
Alarmins in cutaneous malignant melanoma: An updated overview of emerging evidence on their pathogenetic, diagnostic, prognostic, and therapeutic role.

本文引用的文献

1
Low-metastatic melanoma cells acquire enhanced metastatic capability via exosomal transfer of miR-199a-1-5p from highly metastatic melanoma cells.低转移性黑色素瘤细胞通过从高转移性黑色素瘤细胞外泌体转移miR-199a-1-5p获得增强的转移能力。
Cell Death Discov. 2022 Apr 9;8(1):188. doi: 10.1038/s41420-022-00993-8.
2
miR-1227 Targets SEC23A to Regulate the Shedding of Large Extracellular Vesicles.微小RNA-1227靶向SEC23A以调控大型细胞外囊泡的释放
Cancers (Basel). 2021 Nov 22;13(22):5850. doi: 10.3390/cancers13225850.
3
SEC23A Inhibit Melanoma Metastatic through Secretory PF4 Cooperation with SPARC to Inhibit MAPK Signaling Pathway.
皮肤恶性黑色素瘤中的警报素:对其发病机制、诊断、预后和治疗作用的新兴证据的最新综述。
J Dermatol. 2024 Jul;51(7):927-938. doi: 10.1111/1346-8138.17278. Epub 2024 May 22.
SEC23A 通过与 PF4 的分泌合作抑制 SPARC,从而抑制 MAPK 信号通路,进而抑制黑色素瘤转移。
Int J Biol Sci. 2021 Jul 13;17(12):3000-3012. doi: 10.7150/ijbs.60866. eCollection 2021.
4
CXCL3 Signaling in the Tumor Microenvironment.CXCL3 信号在肿瘤微环境中的作用。
Adv Exp Med Biol. 2021;1302:15-24. doi: 10.1007/978-3-030-62658-7_2.
5
Differences in Tumor Immune Microenvironment in Metastatic Sites of Breast Cancer.乳腺癌转移部位肿瘤免疫微环境的差异
Front Oncol. 2021 Mar 18;11:649004. doi: 10.3389/fonc.2021.649004. eCollection 2021.
6
Regulation of Glycolysis in Head and Neck Cancer.头颈部癌症中糖酵解的调控。
Adv Exp Med Biol. 2021;1280:219-230. doi: 10.1007/978-3-030-51652-9_15.
7
Therapeutic Targeting of the Tumour Microenvironment in Metastatic Colorectal Cancer.转移性结直肠癌的肿瘤微环境治疗靶点。
Int J Mol Sci. 2021 Feb 19;22(4):2067. doi: 10.3390/ijms22042067.
8
LASSO-Based Machine Learning Algorithm for Prediction of Lymph Node Metastasis in T1 Colorectal Cancer.基于 LASSO 的机器学习算法在 T1 结直肠癌淋巴结转移预测中的应用。
Cancer Res Treat. 2021 Jul;53(3):773-783. doi: 10.4143/crt.2020.974. Epub 2020 Dec 29.
9
A lncRNA prognostic signature associated with immune infiltration and tumour mutation burden in breast cancer.一个与乳腺癌免疫浸润和肿瘤突变负荷相关的 lncRNA 预后标志物。
J Cell Mol Med. 2020 Nov;24(21):12444-12456. doi: 10.1111/jcmm.15762. Epub 2020 Sep 23.
10
S100A8 transported by SEC23A inhibits metastatic colonization via autocrine activation of autophagy.SEC23A 转运的 S100A8 通过自分泌激活自噬抑制转移定植。
Cell Death Dis. 2020 Aug 6;11(8):650. doi: 10.1038/s41419-020-02835-w.